Enhancing the Visibility of Women in the ACS Division of Medicinal Chemistry (ACS MEDI) von Aldrich, Jane, Allen, Shelley, Araujo, Erika, Bronson, Joanne, Bryant-Friedrich, Amanda, Cyr, Shana K., DiMauro, Erin F., Dzierba, Carolyn, Garner, Amanda L., Georg, Gunda I., Goodwin, Nicole C., Haranahalli, Krupanandan, Huang, Rong, Leftheris, Katerina, May-Dracka, Tricia L., Olson, Margaret E., Blanco, Maria-Jesus

Volltext

Securing and Maintaining a Strong Patent Portfolio for Pharmaceuticals von Weingarten, M. David, Cyr, Shana K

Volltext

Enhancing the Visibility of Women in the ACS Division of Medicinal Chemistry (ACS MEDI) von Aldrich, Jane, Allen, Shelley, Araujo, Erika, Bronson, Joanne, Bryant-Friedrich, Amanda, Cyr, Shana K., DiMauro, Erin F., Dzierba, Carolyn, Garner, Amanda L., Georg, Gunda I., Goodwin, Nicole C., Haranahalli, Krupanandan, Huang, Rong, Leftheris, Katerina, May-Dracka, Tricia L., Olson, Margaret E., Blanco, Maria-Jesus

Volltext

Government regulation of nanorobots in medicine: How the FDA and PTO handle these new technologies von Jessica LA Marks, Shana K Cyr

Volltext

Experts in Patent Cases: A Three-Part Examination of Federal Rules of Evidence 701-706 von Feldstein, Mark J, Cyr, Shana K, Horn, Kelly S

Volltext

Experts in Patent Cases: A Three-Part Examination of Federal Rules of Evidence 701-706 von Feldstein, Mark J, Horn, Kelly S, Cyr, Shana K

Volltext

Experts in Patent Cases: A Three-Part Examination of Federal Rules of Evidence 701-706 von Feldstein, Mark J, Cyr, Shana K, Horn, Kelly S

Volltext

FDA Amends Regulations for 505(b)(2) Applications and ANDAs-Part II von Cyr, Shana K, Feng, Li, Irving, Thomas L

Volltext

FDA Amends Regulations for 505(b)(2) Applications and ANDAs-Part I von Cyr, Shana K, Feng, Li, Irving, Thomas L

Volltext

FDA amends regulations for 505(b)(2) applications and ANDAs von Cyr, Shana K, Feng, Li, Irving, Thomas L

Volltext

FDA amends regulations for 505 von Cyr, Shana K, Feng, Li, Irving, Thomas L

Volltext